TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
2.900
-0.010 (-0.34%)
Nov 20, 2024, 4:00 PM EST - Market closed
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $114.23 million as of November 21, 2024. Its market cap has decreased by -16.40% in one year.
Market Cap
114.23M
Enterprise Value
138.45M
1-Year Change
-16.40%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $146.94M to $114.23M, a decrease of -22.26%. That is a compound annual growth rate of -4.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 114.62M | -29.30% |
| Dec 29, 2023 | 162.12M | -26.42% |
| Dec 30, 2022 | 220.33M | 18.68% |
| Dec 31, 2021 | 185.65M | -14.47% |
| Dec 31, 2020 | 217.06M | 46.96% |
| Dec 31, 2019 | 147.70M | 0.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| American Well | 117.53M |
| Cibus | 117.39M |
| Eupraxia Pharmaceuticals | 117.27M |
| Rani Therapeutics Holdings | 115.63M |
| Alto Neuroscience | 115.16M |
| Cabaletta Bio | 110.46M |
| Journey Medical | 108.40M |
| Century Therapeutics | 107.14M |